The Clinical Use of Alzheimer’s Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer’s Disease Consortium Survey

BACKGROUND: Recent advances occurred in the field of Alzheimer’s disease (AD) biomarkers and the introduction of a research framework grounded on a biomarker-based definition of AD might have fostered an increased clinical use of AD biomarkers. For this reason, an up-to-date depiction of the clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Caprioglio, Camilla, Garibotto, Valentina, Jessen, Frank, Frölich, Lutz, Allali, Gilles, Assal, Frédéric, Frisoni, Giovanni B., Altomare, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535580/
https://www.ncbi.nlm.nih.gov/pubmed/35912743
http://dx.doi.org/10.3233/JAD-220333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535580/
https://www.ncbi.nlm.nih.gov/pubmed/35912743
http://dx.doi.org/10.3233/JAD-220333

Ejemplares similares